Table 5.
Comparison of expression of CD32 with different genotypes of FcγRIIA and CD16 with different genotypes of FcγRIIIB.
SCD-mild (90) | SCD-severe (61) | |||||
---|---|---|---|---|---|---|
H/H (18) | H/R (33) | R/R (39) | H/H (18) | H/R (23) | R/R (20) | |
(Mean ± S.D.) | (Mean ± S.D.) | (Mean ± S.D.) | (Mean ± S.D.) | (Mean ± S.D.) | (Mean ± S.D.) | |
CD32 (MFI) | 23.68 ± 13.24 | 39.21 ± 23.04 | 23.94 ± 15.85 | 15.49 ± 6.14 | 33.83 ± 19.96 | 27.32 ± 18.8 |
| ||||||
NA1/NA2 (44) | NA2/NA2 (46) | NA1/NA2 (36) | NA2/NA2 (25) | |||
| ||||||
CD16 (MFI) | 171.33 ± 85.08 | 162.22 ± 69.42 | 177.59 ± 88.61 | 206.48 ± 92.60 |
Student's t test analysis comparing expression levels with different genotypes among mild versus severe SCD patients:
H/H: P-0.023; H/R: P-0.37; R/R: P-0.47.
NA1/NA2: P-0.75, NA2/NA2: P-0.03.